DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Onxol (Paclitaxel) - Current Clinical Trials

 
 



Onxol Related Clinical Trials

Hepatic Arterial Infusion (HAI) of Abraxane [Active, not recruiting]

Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma [Active, not recruiting]

Phase I & II Trial of Intravesicular Abraxane for Treatment-refractory Bladder Cancer [Recruiting]

A Phase I Trial of the Combination of AZD2014 and Weekly Paclitaxel. [Recruiting]

BKM120 + Carboplatin + Paclitaxel for Patients With Advanced Solid Tumors [Recruiting]

Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma [Completed]

Open-label Phase 1b Study of ARQ 092 in Combination With Carboplatin Plus Paclitaxel [Recruiting]

Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer [Recruiting]

A Randomized Study of Intraperitoneal tgDCC-E1 and Intravenous Paclitaxel in Women With Platinum-Resistant Ovarian Cancer [Withdrawn]

Safety and Efficacy Study of Nab®-Paclitaxel With CC-486 and Nab®-Paclitaxel Monotherapy as Second Line Treatment for Advanced Nonsquamous Non-small Cell Lung Cancer [Recruiting]

Gemcitabine, Cisplatin, and Abraxane in Advanced Biliary Cancers [Recruiting]

A Phase I Trial of Abraxane, Cisplatin and 5-Fluorouracil Along With Chemoradiotherapy in Advanced Head and Neck Cancer [Active, not recruiting]

Intraperitoneal tgDCC-E1 and Intravenous Paclitaxel in Women With Platinum-Resistant Ovarian Cancer [Terminated]

Trial of Paclitaxel/Bevacizumab +/- Everolimus for Patients With HER2-Negative Metastatic Breast Cancer [Completed]

Phase I/II Trial of the Combination of Lenalidomide (Revlimid) and Nab-paclitaxel (Abraxane) in the Treatment of Relapsed/Refractory Multiple Myeloma [Recruiting]

Phase 1b/2 Study of U3-1287 in Combination With Trastuzumab Plus Paclitaxel in Newly Diagnosed Metastatic Breast Cancer (MBC) [Active, not recruiting]

Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer [Recruiting]

PH I SRC Kinase, Dasatinib Combo Paclitaxel & Carboplatin in Pts w Ovarian, Peritoneal, & Tubal Cancer [Completed]

Breast Cancer Treatment Using Weekly Carboplatin + Paclitaxel With Pertuzumab + Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting [Recruiting]

Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer) [Completed]

Schedules of Nab-Paclitaxel in Metastatic Breast Cancer [Active, not recruiting]

Phase II Study of Abraxane Plus Ipilimumab in Patients With Metastatic Melanoma [Recruiting]

Assessment Of Stromal Response To Nab-Paclitaxel In Combination With Gemcitabine In Pancreatic Cancer [Completed]

HAI Abraxane With Gemcitabine and Bevacizumab [Completed]

Study of Vemurafenib, Carboplatin, and Paclitaxel [Recruiting]

Dose Escalation and Pharmacokinetic Study of Paclitaxel Liposome Injection in Treating Patients With Advanced Solid Tumor After Failure From Conventional Treatments [Recruiting]

Neoadjuvant Trial of Nab-Paclitaxel and MPDL3280A [Not yet recruiting]

Dasatinib In Combination With Weekly Paclitaxel For Patients With Metastatic Breast Carcinoma CA 180 194 [Active, not recruiting]

Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer [Recruiting]

Nab-paclitaxel in Combination With Gemcitabine in Fragile Patients With Advanced Pancreatic Cancer [Recruiting]

A Study of Ramucirumab (IMC-1121B) and Paclitaxel in Participants With Solid Tumors [Active, not recruiting]

PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Subjects With Stage IV Untreated Pancreatic Cancer [Recruiting]

HSP90 Inhibitor AT13387 and Paclitaxel in Treating Patients With Advanced Triple Negative Breast Cancer [Not yet recruiting]

Bioequivalence Study of IG-001 Versus Nab-paclitaxel in Metastatic or Locally Recurrent Breast Cancer [Active, not recruiting]

Safety and Efficacy Study of Abraxane Plus Gemcitabine in Chinese Patients With Metastatic Pancreatic Cancer [Active, not recruiting]

Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer [Completed]

Investigating Safety, Tolerability and Efficacy of AZD5363 When Combined With Paclitaxel in Breast Cancer Patients [Recruiting]

Study Comparing Nanoparticle-based Paclitaxel With Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Patients With Early Breast Cancer (GeparSepto) [Active, not recruiting]

Paclitaxel-Carboplatin-Bevacizumab +/- Nitroglycerin in Metastatic Non-Squamous-Non-Small Cell Lung Cancer [Recruiting]

Study of Concurrent Paclitaxel and Radiation: Correlation of Tumor Profiles With Pathologic Response [Recruiting]

A Study of BIIB022 in Combination With Paclitaxel and Carboplatin in Subjects With Non-Small Cell Lung Cancer [Completed]

Lenalidomide and Paclitaxel in Prostate Cancer [Active, not recruiting]

Phase II Trial Comparing ABI-007 (Abraxane®, Nab®-Paclitaxel) to Taxotere in First Line Therapy of Patients With Stage IV Breast Cancer [Completed]

Abraxane in CIMP-High Colorectal and Small Bowel Adenocarcinomas [Active, not recruiting]

MK2206 and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Metastatic Breast Cancer [Active, not recruiting]

A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Metastatic Malignant Melanoma [Completed]

Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer [Recruiting]

Study of Nab-Paclitaxel and Ramucirumab as Second-line Treatment for Patients With Metastatic Gastroesophageal Cancer [Recruiting]

Efficacy of ABI-007 Plus Gemcitabine or sLV5FU2 as First-line Therapy in Patients With Metastatic Pancreatic Cancer [Active, not recruiting]

Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC) [Recruiting]

Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metastatic Breast Cancer [Terminated]

Hepatic Arterial Infusion of Nab-Paclitaxel in Patients With Metastatic Melanoma in the Liver [Completed]

Phase II Neoadjuvant Chemotheraphy (Gemcitabine and Nab-Paclitaxel vs. mFOLFIRINOX) and Sterotatic Body Radiation Therapy for Borderline Resectable Pancreatic Cancer [Recruiting]

Trial to Evaluate Paclitaxel Plus RAD001 in Urothelial Carcinoma [Terminated]

Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer [Active, not recruiting]

ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer [Completed]

Paclitaxel Administered by HAI to Patients With Advanced Cancer and Dominant Liver Involvement [Completed]

Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian Origin [Active, not recruiting]

Study of Afuresertib Combined With Paclitaxel in Gastric Cancer [Recruiting]

Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced Malignancies [Recruiting]

Trial of Combination ABI-007, Carboplatin, and Gemcitabine for First Line Treatment of Advanced Urothelial Cancer [Completed]

Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer [Completed]

F16IL2 Plus Paclitaxel in Metastatic Merkel Cell Carcinoma [Recruiting]

To Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors [Recruiting]

Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia [Recruiting]

Temsirolimus + Weekly Paclitaxel + Carboplatin for Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC) [Active, not recruiting]

Phase I/Ib Study of Paclitaxel in Combination With VS-6063 in Patients With Advanced Ovarian Cancer [Active, not recruiting]

Bevacizumab and Abraxane as Second-line Therapy in Triple Negative Metastatic Breast Cancer [Completed]

A Phase I/II Study of ABI-007 (Abraxane®, Nab®-Paclitaxel)and Vinorelbine in Patients With Stage IV (Metastatic) Breast Cancer [Terminated]

M402 in Combination With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer [Recruiting]

A Phase 3 Study to Compare Efficacy and Safety of DHP107 Versus Taxol® in Patients With Metastatic or Recurrent Gastric Cancer After Failure of First-line Chemotherapy [Completed]

Cisplatin, Temozolomide, Abraxane, With Interleukin-2 and Interferon for Metastatic Melanoma [Completed]

Metformin Plus Paclitaxel for Metastatic or Recurrent Head and Neck Cancer [Terminated]

Dasatinib, Bevacizumab, Paclitaxel in Patients With Advanced Malignancies [Active, not recruiting]

A Study of Paclitaxel/Carboplatin With or Without CDP791 in Patients With Lung Cancer [Completed]

Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery [Recruiting]

Treatment With Nab-paclitaxel in Cutaneous SCC [Not yet recruiting]

Phase I Dose Escalation of Oral BAY1161909 in Combination With Intravenous Paclitaxel [Recruiting]

First-line Treatment of Weekly Paclitaxel With Carboplatin and Bevacizumab in Ovarian Cancer [Active, not recruiting]

Phase IB/II Trial of LDE225 and Paclitaxel in Recurrent Ovarian Cancer [Recruiting]

A Phase I/II Study of Nab-Paclitaxel, or Paclitaxel, Plus Carboplatin With Concurrent Radiation Therapy Followed by Consolidation in Patients With Favorable Prognosis Inoperable Stage IIIA/B NSCLC [Recruiting]

Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma [Completed]

Cisplatin vs Paclitaxel for Triple Neg [Recruiting]

Paclitaxel, Bevacizumab and Pemetrexed in Patients With Untreated, Advanced Non-Small Cell Lung Cancer Using Web-Based Data Collection, Patient Self-Reporting of Adverse Effects and Automated Response Assessment [Completed]

LDE225 and Paclitaxel in Solid Tumors [Active, not recruiting]

Nab-paclitaxel Plus S-1 in Patients With Advanced Pancreatic Cancer [Recruiting]

Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast Cancer [Active, not recruiting]

Fosbretabulin or Placebo in Combination With Carboplatin/Paclitaxel in Anaplastic Thyroid Cancer [Withdrawn]

Albumin-bound Paclitaxel (ABI-007) for Patients With Advanced Non-Small Cell Lung Cancer [Completed]

Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast Cancer [Completed]

Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Advanced Pancreatic Cancer [Recruiting]

Prevention of Paclitaxel Neuropathy With Cryotherapy [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017